Article Details
Retrieved on: 2025-02-03 18:29:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the CHMP's recommendation for two aflibercept biosimilars by Amgen for treating AMD and other retinal conditions. This aligns with the key concept of 'AMD' and tags focusing on angiogenesis inhibitors and related medications.
Article found on: europe.ophthalmologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here